Enarodustat, a Hypoxia‐Inducible Factor Prolyl Hydroxylase Inhibitor, Does Not Exacerbate Peritoneal Inflammation or Subsequent Fibrosis in a Rat Model of Peritonitis Induced by Mechanical Scraping
Therapeutic Apheresis and Dialysis · 20.11.2026
DOI: 10.1002/1744-9987.70245 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, online erschienen am 20.11.2026. Verfasst von Satoshi Ototake und 7 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Introduction
Hypoxia‐inducible factor (HIF) prolyl hydroxylase inhibitors (PHIs) are widely used to treat renal anemia, but their effects on peritoneal injury during peritoneal dialysis remain poorly understood. We investigated the impact of enarodustat, an HIF‐PHI, on peritoneal injury and fibrosis.
Methods
Peritoneal injury was induced in 8‐week‐old Sprague–Dawley rats by mechanical scraping. Those rats were randomized to receive vehicle or enarodustat (0.3 or 3.0 mg/kg) once daily by oral gavage for 7 days or 14 days. On Days 7 and 14, the parietal peritoneum was evaluated histologically and immunobiologically for thickening, fibrosis, and inflammatory cell infiltration. Protein and mRNA expression levels from peritoneal tissue were quantified.
Results
Enarodustat did not significantly increase peritoneal thickness, fibrosis, inflammatory infiltration, or markers of fibrosis or inflammation compared with vehicle on either day, although red blood cell counts increased.
Conclusion
Enarodustat did not aggravate peritoneal inflammation or fibrosis in this short‐term experimental model.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Ototake, S., Kim, H., Ozeki, T., Kamegai, N., Fukui, S., Suzuki, Y., Maruyama, S., & Mizuno, M. (2026). Enarodustat, a Hypoxia‐Inducible Factor Prolyl Hydroxylase Inhibitor, Does Not Exacerbate Peritoneal Inflammation or Subsequent Fibrosis in a Rat Model of Peritonitis Induced by Mechanical Scraping. Therapeutic Apheresis and Dialysis. https://doi.org/10.1002/1744-9987.70245
Vancouver
Ototake S, Kim H, Ozeki T, Kamegai N, Fukui S, Suzuki Y, et al. Enarodustat, a Hypoxia‐Inducible Factor Prolyl Hydroxylase Inhibitor, Does Not Exacerbate Peritoneal Inflammation or Subsequent Fibrosis in a Rat Model of Peritonitis Induced by Mechanical Scraping. Therapeutic Apheresis and Dialysis. 2026. doi:10.1002/1744-9987.70245
BibTeX
@article{Ototake2026,
author = {Ototake, Satoshi and Kim, Hangsoo and Ozeki, Toshikazu and Kamegai, Naoki and Fukui, Sosuke and Suzuki, Yasuhiro and Maruyama, Shoichi and Mizuno, Masashi},
title = {Enarodustat, a Hypoxia‐Inducible Factor Prolyl Hydroxylase Inhibitor, Does Not Exacerbate Peritoneal Inflammation or Subsequent Fibrosis in a Rat Model of Peritonitis Induced by Mechanical Scraping},
journal = {Therapeutic Apheresis and Dialysis},
year = {2026},
doi = {10.1002/1744-9987.70245}
}
EUVIMED